Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.

Animals Anti-Bacterial Agents / pharmacology Cattle Cattle Diseases / epidemiology Cefotaxime / pharmacology Cross-Sectional Studies Drug Resistance, Bacterial Escherichia coli / drug effects Escherichia coli Infections / epidemiology Genotype Microbial Sensitivity Tests / veterinary Phenotype Prevalence Sheep Sheep Diseases / epidemiology Spain / epidemiology
AMR AmpC AmpC β-lactamase-producing E. coli ESBL MIC WGS antimicrobial resistance beef cattle dairy cattle extended-spectrum β-lactamase-producing E. coli minimum inhibitory concentration sheep whole-genome sequencing

Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 27 03 2020
accepted: 26 05 2020
pubmed: 31 5 2020
medline: 11 11 2020
entrez: 31 5 2020
Statut: epublish

Résumé

In order to estimate herd-level prevalence of extended-spectrum β-lactamase/AmpC β-lactamase (ESBL/AmpC)- and carbapenemase-producing commensal

Identifiants

DOI: 10.1128/AEM.00742-20 PMID: 32471914 PMC: PMC7376548
pubmed: 32471914
pii: AEM.00742-20
doi: 10.1128/AEM.00742-20
pmc: PMC7376548
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cefotaxime N2GI8B1GK7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Clin Microbiol Infect. 2018 Dec;24(12):1241-1250
pubmed: 29654871
J Dairy Sci. 2016 Nov;99(11):9001-9013
pubmed: 27638264
FEMS Microbiol Rev. 2010 May;34(3):295-316
pubmed: 20030731
J Antimicrob Chemother. 2012 Jun;67(6):1368-74
pubmed: 22382469
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
J Microbiol Methods. 2003 Jan;52(1):123-31
pubmed: 12401234
J Antimicrob Chemother. 2016 May;71(5):1178-82
pubmed: 26803720
Front Microbiol. 2011 Dec 19;2:246
pubmed: 22203818
Front Microbiol. 2012 Apr 02;3:110
pubmed: 22485109
BMC Vet Res. 2012 Mar 07;8:21
pubmed: 22397509
Drug Resist Updat. 2013 Feb-Apr;16(1-2):22-45
pubmed: 23395305
mBio. 2017 Aug 29;8(4):
pubmed: 28851843
J Antimicrob Chemother. 2015 Sep;70(9):2528-35
pubmed: 26071519
Antimicrob Agents Chemother. 2005 Mar;49(3):1262-4
pubmed: 15728945
Prev Vet Med. 2017 Jul 1;142:39-45
pubmed: 28606364
Vet Microbiol. 2017 Feb;200:142-150
pubmed: 27634182
Antimicrob Agents Chemother. 2015 May;59(5):2964-6
pubmed: 25691650
Pathogens. 2019 Jul 08;8(3):
pubmed: 31288484
EFSA J. 2019 Feb 27;17(2):e05598
pubmed: 32626224
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Ther Adv Infect Dis. 2016 Feb;3(1):15-21
pubmed: 26862399
Front Microbiol. 2012 Feb 02;3:24
pubmed: 22347217
Bioinformatics. 2019 Nov 1;35(21):4207-4212
pubmed: 30957837
Nucleic Acids Res. 2018 Apr 6;46(6):e35
pubmed: 29346586
Antimicrob Agents Chemother. 2004 Jan;48(1):1-14
pubmed: 14693512
J Antimicrob Chemother. 2010 Mar;65(3):460-4
pubmed: 20097787
PLoS One. 2018 Nov 26;13(11):e0207857
pubmed: 30475879
J Antimicrob Chemother. 2017 Oct 1;72(10):2764-2768
pubmed: 29091202
mBio. 2019 Jan 22;10(1):
pubmed: 30670621
FEMS Microbiol Lett. 2008 May;282(2):238-40
pubmed: 18371063
Antimicrob Agents Chemother. 2014;58(3):1822-4
pubmed: 24395224
Methods Mol Biol. 2020;2075:285-294
pubmed: 31584170
J Antimicrob Chemother. 2018 Feb 1;73(2):339-347
pubmed: 29165596
J Antimicrob Chemother. 2018 May 1;73(5):1121-1137
pubmed: 29370371
Front Microbiol. 2019 Feb 04;10:76
pubmed: 30778339
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28533247
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30003869
J Antimicrob Chemother. 2019 Mar 1;74(3):639-644
pubmed: 30544192
Front Microbiol. 2019 Jun 12;10:1311
pubmed: 31244817
Sci Rep. 2019 Apr 15;9(1):6089
pubmed: 30988366
Vet Microbiol. 2017 Oct;210:71-76
pubmed: 29103699
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Epidemiol Infect. 2019 Jan;147:e164
pubmed: 31063106
J Clin Microbiol. 2010 Aug;48(8):2840-5
pubmed: 20519460
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Emerg Infect Dis. 2009 Oct;15(10):1648-50
pubmed: 19861064
Appl Environ Microbiol. 2013 May;79(9):3027-32
pubmed: 23455336
J Comput Biol. 2000 Feb-Apr;7(1-2):203-14
pubmed: 10890397
mSphere. 2019 May 8;4(3):
pubmed: 31068437
Foodborne Pathog Dis. 2019 Jan;16(1):5-22
pubmed: 30418042
Heliyon. 2020 Jan 30;6(1):e03206
pubmed: 32042963
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):821-4
pubmed: 21894534
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674050
Lancet Planet Health. 2019 Aug;3(8):e357-e369
pubmed: 31439317
Crit Rev Microbiol. 2017 Feb;43(1):1-30
pubmed: 27786586
Antimicrob Agents Chemother. 2011 Sep;55(9):3985-9
pubmed: 21690279

Auteurs

Maitane Tello (M)

Animal Health Department, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
ORCID: 0000-0002-2726-4634

Medelin Ocejo (M)

Animal Health Department, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
ORCID: 0000-0001-5136-956X

Beatriz Oporto (B)

Animal Health Department, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
ORCID: 0000-0001-8896-6245

Ana Hurtado (A)

Animal Health Department, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain ahurtado@neiker.eus.
ORCID: 0000-0001-7089-9670

Articles similaires

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Ruminants › Bovins › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Maladies de l'animal › Maladies des bovins › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Céfacétrile › Céfotaxime › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Escherichia coli › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Phénomènes génétiques › Phénotype › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Ruminants › Ovis › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Maladies de l'animal › Maladies des ovins › Prevalence of Cefotaxime-Resistant Escherichia...
questionsmedicales.fr › Régions géographiques › Europe › Espagne › Prevalence of Cefotaxime-Resistant Escherichia...